PBL Assay Science

Executive Summary

PBL Assay Science is a US-based provider of high-quality research tools and contract assay services, with a focus on immunology and virology. Founded in 1992 and headquartered in Piscataway, New Jersey, the company supplies cytokines, antibodies, and assay kits to academic, biotech, and pharmaceutical customers. Its custom assay development and testing capabilities position it as a critical enabler for basic and translational research. While the company operates in a niche but essential segment of the life sciences tools market, its long history and established reputation suggest steady demand from repeat customers. However, as a privately held firm with no disclosed funding or valuation, growth prospects appear modest, and the company faces competition from larger reagent vendors. Overall, PBL Assay Science represents a stable, low-growth business with a loyal customer base, but limited upside catalysts in the near term.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation cytokine assay kits targeting emerging infectious diseases70% success
• H1 2027Expansion of contract assay services to support biotech and pharma clinical-stage programs60% success
• TBDStrategic partnership with a major pharmaceutical company for custom immunoassay development40% success